Pfizer writes to PM to calm AstraZeneca takeover fears

clock

Pfizer, the US pharmaceuticals giant which today raised its offer for UK rival AstraZeneca, has written to Prime Minister David Cameron in an attempt to appease fears over the impact of any takeover.

The group - which made a revised offer of £50 per share for AstraZeneca - told the PM it would make a number of concessions if any deal was approved in order to protect an industry that is crucial to the UK. "We recognize that our approach may create uncertainty for the UK Government and scientific community given the strategic importance of life sciences to the Government's Industrial Strategy and the significance of the transaction," it said. "We would therefore like to assure the Government of our long term commitment to the UK where Pfizer already employs a significant number of c...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Equities

Pictet AM launches AI-backed global equity fund

Pictet AM launches AI-backed global equity fund

Using AI for stock selection

clock 18 April 2024 • 1 min read
Robeco to launch equity and credit 'transition investing' funds

Robeco to launch equity and credit 'transition investing' funds

Emerging markets and Asia

clock 15 April 2024 • 2 min read
GB ISA panel: Success for UK equities will be in the details

GB ISA panel: Success for UK equities will be in the details

Video roundtable

Cristian Angeloni
clock 04 April 2024 • 1 min read
Trustpilot